WINDLAS2024-10-012024-12-31 WINDLAS2024-10-012024-12-31 WINDLAS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member WINDLAS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses02Member WINDLAS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses03Member WINDLAS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses04Member WINDLAS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses05Member WINDLAS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses06Member WINDLAS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses07Member WINDLAS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses08Member WINDLAS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses09Member WINDLAS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses10Member WINDLAS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member WINDLAS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses02Member WINDLAS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses03Member WINDLAS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses04Member WINDLAS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses05Member WINDLAS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses06Member WINDLAS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses07Member WINDLAS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses08Member WINDLAS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses09Member WINDLAS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses10Member WINDLAS2024-12-31 WINDLAS2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member WINDLAS2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member WINDLAS2024-10-012024-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member WINDLAS2024-10-012024-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543329 WINDLAS NOTLISTED Windlas Biotech Limited Equity 2024-04-01 2025-03-31 2025-02-11 2025-02-03 INR Millions Third quarter 13:30:00 14:45:00 2025-02-11 2025-02-11 Not applicable Single segment Pharmaceuticals 2024-10-01 2024-12-31 Unaudited Consolidated 1950190000.00 41070000.00 1991260000.00 8770000.00 1336360000.00 -136810000.00 321720000.00 14600000.00 69390000.00 173850000.00 1787880000.00 203380000.00 0.00 203380000.00 39420000.00 8200000.00 47620000.00 0.00 155760000.00 0.00 0.00 0.00 0.00 155760000.00 -210000.00 155550000.00 0.00 0.00 0.00 0.00 104500000.00 5 7.45 7.38 0.00 0.00 7.45 7.38 Single segment 2024-04-01 2024-12-31 Unaudited Consolidated 5571730000.00 130810000.00 5702540000.00 -10030000.00 3792850000.00 -316180000.00 909890000.00 30550000.00 196500000.00 509610000.00 5113190000.00 589350000.00 0.00 589350000.00 136860000.00 5360000.00 142220000.00 0.00 447130000.00 0.00 0.00 0.00 0.00 447130000.00 -7080000.00 440050000.00 0.00 0.00 0.00 0.00 104500000.00 5 21.42 21.20 0.00 0.00 21.42 21.20 Advertisement and Publicity 8090000.00 Commission on sales 15560000.00 Freight and carriage 24290000.00 Lab Testing Expenses 9810000.00 Other Expenses 27740000.00 Power & fuel 51230000.00 Repairs & Maintenance 5170000.00 Research & Development Expenses 17880000.00 Security expenses 5180000.00 Traveling Expenses 8900000.00 Advertisement and Publicity 19510000.00 Commission on sales 60220000.00 Freight and carriage 63660000.00 Lab Testing Expenses 21070000.00 Other Expenses 78970000.00 Power & fuel 158780000.00 Repairs & Maintenance 22180000.00 Research & Development Expenses 46800000.00 Security expenses 14740000.00 Traveling Expenses 23680000.00 Remeasurement of defined benefit plans- gain/(loss) -430000.00 Remeasurement of defined benefit plans- gain/(loss) -9590000.00 -430000.00 -9590000.00 -100000.00 -2410000.00 Foreign currency translation reserve 120000.00 Foreign currency translation reserve 100000.00 120000.00 100000.00 0.00 0.00